
    
      Study Type: Interventional Study Design: Single-dose two-way, crossover bioequivalence study
      with an adequate washout period (7 days) between the two periods of the study and with an
      equal number of subjects randomly assigned to receive the study test (Treatment A) and study
      reference (Treatment B).

      Official Title: Single Dose Two-Way Crossover Fasted Bioequivalence Study of Cetirizine
      Hydrochloride 10 mg Tablets in Healthy Volunteers

      Further study details as provided by Actavis Elizabeth LLC:

      Primary Outcome Measures:

      Rate and Extend of Absorption
    
  